Press release
Global Biologics Market to grow at a CAGR of 9.59% by 2030, Evaluates DelveInsight | GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, Merck & Co., Inc, Novo Nordisk, Novartis AG, Pfizer Inc, AstraZeneca
DelveInsight's "Biologics Market Insights, Competitive Landscape and Market Forecast-2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Biologics companies actively working in the market.
To know more about why North America is leading the market growth in the Biologics market, get a snapshot of the report Biologics Market Trends
https://www.delveinsight.com/sample-request/biologics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Biologics Overview
Biologics are advanced medical products derived from living organisms. They include a wide range of treatments such as vaccines, blood components, gene therapies, and monoclonal antibodies. Unlike traditional drugs made through chemical synthesis, biologics are typically large, complex molecules produced using biotechnology methods. These therapies are designed to target specific components of the immune system and are commonly used to treat chronic diseases like cancer, autoimmune disorders, and rare genetic conditions. Their precision and effectiveness make them a rapidly growing area in modern medicine.
DelveInsight Analysis: The global biologics market reached a valuation of USD 333.10 billion in 2023 and is projected to grow at a CAGR of 9.59% between 2024 and 2030, eventually surpassing USD 577.03 billion by 2030.
Biologics Market Insights
Geographically, North America is projected to dominate the global biologic drugs market, largely due to its strong emphasis on developing therapies for rare diseases with orphan drug status, along with the increasing incidence of cancer and favorable regulatory frameworks. Additionally, factors such as high disposable income, advanced healthcare infrastructure, greater awareness of innovative treatments, and widespread insurance coverage are expected to further drive market growth in the region.
To read more about the latest highlights related to Biologics, get a snapshot of the key highlights entailed in the Biologics
https://www.delveinsight.com/report-store/biologics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Biologics Market Report
• In October 2021, The US FDA has granted approval to Genentech, Inc.'s atezolizumab (Tecentriq) for use as an adjuvant therapy in patients with stage II to IIIA non-small cell lung cancer (NSCLC) following surgical resection and platinum-based chemotherapy.
• In August 2021, Bristol Myers Squibb was granted conditional marketing authorization by the European Commission for Abecma (idecabtagene vicleucel) to treat adult patients with relapsed and refractory multiple myeloma. Abecma is a first-in-class CAR T cell immunotherapy targeting B-cell maturation antigen (BCMA).
• In June 2021, The US FDA granted accelerated approval to Biogen Inc.'s Aduhelm (aducanumab) for the treatment of Alzheimer's disease.
• Thus, owing to such developments in the market, rapid growth will be observed in the Biologics market during the forecast period
Key Players in the Biologics Market
Some of the key market players operating in the Biologics market include- GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, Merck & Co., Inc, Novo Nordisk, Novartis AG, Pfizer Inc, AstraZeneca, Bristol Myers Squibb., Regeneron Pharmaceuticals Inc., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH., Genentech, Inc, Biogen., bluebird bio, Inc, Janssen Global Services, LLC,., Cellitron Group and others.
Which MedTech key players in the Biologics market are set to emerge as the trendsetter explore @ Key Biologics Companies
https://www.delveinsight.com/sample-request/biologics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Covid-19 Impact Analysis on the Biologics Market Landscape
The biologics market was among the few sectors that experienced positive growth during the COVID-19 pandemic. While global lockdowns disrupted manufacturing in many industries, the pressing need to develop COVID-19 vaccines created significant opportunities for biopharmaceutical companies. The emergency use authorization of the first COVID-19 vaccine-Pfizer-BioNTech-in late December 2020 marked a turning point, accelerating vaccine development and approvals worldwide.
In recent years, monoclonal antibodies have received approvals for a variety of conditions including migraine, rheumatoid arthritis, and HIV. With the emergence of the COVID-19 pandemic, efforts to develop targeted therapies have intensified. For example, in November 2021, Celltrion Group secured marketing authorization for Regkirona, a monoclonal antibody treatment for patients aged 12 and above who do not require supplemental oxygen but are at high risk of developing severe COVID-19.
Given their therapeutic benefits and expanding applications, monoclonal antibodies are anticipated to experience significant growth, thereby boosting the overall biologics market during the forecast period.
Scope of the Biologics Market Report
• Coverage: Global
• Study Period: 2021-2030
• Biologics Market Segmentation By Type: Cell-Based Biologics, Gene-Based Biologics, Monoclonal Antibodies, Vaccines, Recombinant Proteins, And Others
• Biologics Market Segmentation By Application Type: Oncology, Immunology, Infectious Diseases, Neurological Diseases, And Others
• Biologics Market Segmentation By Manufacturing Type: In-House And Outsourced
• Biologics Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Biologics Companies: GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, Merck & Co., Inc, Novo Nordisk, Novartis AG, Pfizer Inc, AstraZeneca, Bristol Myers Squibb., Regeneron Pharmaceuticals Inc., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH., Genentech, Inc, Biogen., bluebird bio, Inc, Janssen Global Services, LLC,., Cellitron Group and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Biologics market will grow by 2030? Click to get a snapshot of the Biologics Market Analysis
https://www.delveinsight.com/sample-request/biologics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Biologics Market Report Introduction
2 Biologics Market Executive summary
3 Regulatory and Patent Analysis
4 Biologics Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Biologics Market
7 Biologics Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Project Approach
11 Biologics Market Drivers
12 Biologics Market Barriers
13 About DelveInsight
Latest Reports by DelveInsight
• Global Kinase Inhibitor Market: https://www.delveinsight.com/report-store/global-kinase-inhibitor-in-autoimmune-diseases-market-insight
• Nerve Repair And Regeneration Devices- Market Insights: https://www.delveinsight.com/report-store/nerve-repair-and-regeneration-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Diabetic Wound Market: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
• Sglt2 Inhibitors Market: https://www.delveinsight.com/report-store/sglt2-inhibitors-market
• Electroencephelographs Pipeline Insight: https://www.delveinsight.com/report-store/epilepsy-pipeline-insight
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
Connect With Us at:
LinkedIn | Facebook | Twitter
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biologics Market to grow at a CAGR of 9.59% by 2030, Evaluates DelveInsight | GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, Merck & Co., Inc, Novo Nordisk, Novartis AG, Pfizer Inc, AstraZeneca here
News-ID: 4070920 • Views: …
More Releases from DelveInsight Business Research
Sepsis Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight …
DelveInsight's "Sepsis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Sepsis, historical and forecasted epidemiology as well as the Sepsis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Sepsis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Sepsis Market Forecast
https://www.delveinsight.com/sample-request/sepsis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Sepsis…
Global Pupillometer Market to grow at a CAGR of 7.14% by 2030, Evaluates DelveIn …
According to DelveInsight's analysis, the demand for pupillometers is mainly driven by the growing incidence of neurological conditions like brain injury, brain tumors, stroke, Horner's syndrome, and various eye disorders worldwide. Additionally, the increasing use of advanced and innovative technologies, expansion of intensive care units, and the frequent introduction and approval of new products are further fueling the overall growth of the pupillometer market during the forecast period from 2024…
Global Nuclear Medicine Market to grow at a CAGR of 9.67% by 2030, Evaluates Del …
According to DelveInsight's analysis, The nuclear medicine/radiopharmaceuticals market is experiencing significant growth driven by the rising incidence of cancer, cardiovascular conditions, and other chronic illnesses linked to sedentary lifestyles. Moreover, the expanding elderly population-more vulnerable to such diseases-along with the growing global demand for image-guided diagnostics and procedures, and a strong pipeline of upcoming products, is expected to boost market demand. Supportive government initiatives aimed at enhancing access to nuclear…
Global Probiotics Market to grow at a CAGR of 7.66% by 2030, Evaluates DelveInsi …
According to DelveInsight's analysis, The probiotics market is expected to experience strong growth due to several key factors, including growing awareness of digestive health, rising demand for probiotics in preventive healthcare, and expanding use in sports nutrition. Additionally, increased attention to animal health, ongoing product innovation, and a heightened emphasis on probiotic safety are anticipated to significantly boost market revenue throughout the forecast period (2024-2030).
DelveInsight's "Probiotics Market Insights, Competitive Landscape…
More Releases for Biologics
Biopharmaceutical CMO Market 2020 Business Scenario – Lonza, Boehringer Ingelh …
The report provides a valuable source of insightful data for business strategists and competitive analysis of Biopharmaceutical CMO Market. It provides the Biopharmaceutical CMO industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Biopharmaceutical CMO study provides comprehensive data which enhances the understanding, scope and application of this report.
the…
Extracellular Matrix Market Detailed Analysis 2020: Top Companies like Coloplast …
The global extracellular matrix market by raw material segments was led by porcine segment. In 2018, the porcine segment held a largest market share of 41.09% of the extracellular matrix market, by raw material. However, the bovine segment is expected to be the fastest growing segments of the market in 2027 owing to more beneficial properties to treat various conditions which is expected to become the major factor for the…
Biopharmaceutical CMO Market 2018-2023 :Lonza, Boehringer Ingelheium, Samsung Bi …
Global Biopharmaceutical CMO Industry - A Global Market Overview (2018-2023) (Avail A 10% Off)
The "Global Biopharmaceutical CMO Market Research Report 2018-2023" is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides…
Global Biopharmaceutical CMO Market Key Profiles - Wuxi Biologics, Boehringer In …
Global Biopharmaceutical CMO Market was valued at USD 13296.29 million in the year 2019. Escalating number of patients suffering from various diseases with growing investment in the healthcare industry by government in major economies and increasing awareness among consumers regarding impact of various viruses on health, has been anticipated to infuse growth in the market for Biopharmaceutical CMO during the forecasting period of 2020-2025.
Get Free Sample Copy of this Research…
Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development…
Global Biopharmaceutical CMO Market 2018-2023| Lonza, Boehringer Ingelheium, Sam …
Albany, NY, 10th September : Recent research and the current scenario as well as future market potential of "Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) - By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)" globally.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to…
